Quick extrapolation on last years data, obviously these figures remain unaudited but you get a fair idea.
US FY21 ($23.19m, +49%) PCP ($15.57m, +102%)
AUS FY21 ($3.53m, +25%), PCP ($2.82m +80%)
FY Distributor revenue growth is a new metric which wasn't used last year.
I believe this downgrade has already been priced in given the drop from $2.90 to $2.30 in a week, it was put out on the record last year that we expected revenue to double and unfortunately due to COVID we've had growth but it wasn't in the triple digits. I also expect FY22 to be a much bigger year as vaccination rates increase, hospitalisations decrease and our new accounts reach maturity with increased sales staff on board
A good time to continue accumulating.
- Forums
- ASX - By Stock
- PNV
- Ann: FY21 BTM Revenue Results
Ann: FY21 BTM Revenue Results, page-28
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.38 |
Change
0.060(2.59%) |
Mkt cap ! $1.643B |
Open | High | Low | Value | Volume |
$2.35 | $2.39 | $2.33 | $2.357M | 995.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 232 | $2.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 3934 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 232 | 2.370 |
3 | 11692 | 2.360 |
5 | 20879 | 2.350 |
1 | 2161 | 2.340 |
2 | 6978 | 2.330 |
Price($) | Vol. | No. |
---|---|---|
2.380 | 3934 | 1 |
2.390 | 185006 | 6 |
2.400 | 76851 | 7 |
2.410 | 16999 | 4 |
2.420 | 31146 | 3 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online